Erythromycin

Publication Title: 
The Cochrane Database of Systematic Reviews

BACKGROUND: There has been renewal of interest in the use of prophylactic antibiotics to reduce the frequency of exacerbations and improve quality of life in chronic obstructive pulmonary disease (COPD). OBJECTIVES: To determine whether or not regular treatment of COPD patients with prophylactic antibiotics reduces exacerbations or affects quality of life. SEARCH METHODS: We searched the Cochrane Airways Group Trials Register and bibliographies of relevant studies. The latest literature search was August 2013.

Author(s): 
Herath, Samantha C.
Poole, Phillippa
Publication Title: 
The American Journal of Tropical Medicine and Hygiene

In southeast Asia, the widespread high prevalence of counterfeits tablets of the vital antimalarial artesunate is of great public health concern. To assess the seriousness of this problem, we quantified the amount of active ingredient present in artesunate tablets by liquid chromatography coupled to mass spectrometry. This method, in conjunction with analysis of the packaging, classified tablets as genuine, substandard, or fake and validated results of the colorimetric Fast Red TR test.

Author(s): 
Hall, Krystyn Alter
Newton, Paul N.
Green, Michael D.
De Veij, Marleen
Vandenabeele, Peter
Pizzanelli, David
Mayxay, Mayfong
Dondorp, Arjen
Fernández, Facundo M.
Publication Title: 
Zeitschrift Für Hautkrankheiten

Regarding treatment of acne vulgaris and rosacea, there is not much difference between hospital and practice nor among practicing dermatologists. Most of the assistants performing the important physical-manual treatment have had the same training. After analytical conversation and etiologic as well as diagnostic classification, the patients undergo the following manual treatment: cleansing, astringing, removing of comedones, massage, face pack, and covering with tinted emulsion.

Author(s): 
Böcker, K. H.
Publication Title: 
Archives of Disease in Childhood. Fetal and Neonatal Edition

BACKGROUND: It often takes several days or even weeks to establish full enteral feeds (FEFs) in preterm, especially extremely low birthweight neonates because of feed intolerance related to gastrointestinal hypomotility. Clinical trials of erythromycin as a prokinetic agent in preterm neonates have reported conflicting results. AIM: To systematically review the efficacy and safety of erythromycin as a prokinetic agent in preterm neonates. METHODS: Only randomised controlled trials in preterm neonates (gestation < or = 37 weeks) were considered eligible for inclusion.

Author(s): 
Patole, S.
Rao, S.
Doherty, D.
Subscribe to RSS - Erythromycin